Viewing Study NCT00075751


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-04-09 @ 5:44 AM
Study NCT ID: NCT00075751
Status: COMPLETED
Last Update Posted: 2013-02-28
First Post: 2004-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Non-small Cell Lung Cancer View
None Stage IIIB Non-small Cell Lung Cancer View
None Stage IV Non-small Cell Lung Cancer View
Keywords: